Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patientsYang Li, Sheng‐ce Tao, Huiming Sheng et al.|Cell Reports|2021Cited by 183
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infectionsQing Lei, Xionglin Fan, Yang Li et al.|Allergy|2020Cited by 138
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patientsYang Li, Sheng‐ce Tao, Pengfei Pang et al.|Cellular and Molecular Immunology|2021Cited by 57
Nsp2 has the potential to be a drug target revealed by global identification of SARS-CoV-2 Nsp2-interacting proteinsYun-xiao Zheng, Sheng‐ce Tao, Wei-Sha Kong et al.|Acta Biochimica et Biophysica Sinica|2021Cited by 47
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteinsYang Li, Sheng‐ce Tao, Huiming Sheng et al.|Cell Reports|2021Cited by 45